Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Apyx Medical Corporation (APYX : NSDQ)

• Company Description    Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States. Number of Employees: 220

• Price / Volume Information    Yesterday's Closing Price: $3.50 Daily Weekly Monthly 20 Day Moving Average: 50,206 shares Shares Outstanding: 38.24 (millions) Market Capitalization: $133.85 (millions) Beta: 1.53 52 Week High: $4.44 52 Week Low: $0.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.15% -13.00% 12 Week 17.06% 15.17% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5115 Ulmerton Road - Clearwater,FL 33760 USA ph: 727-384-2323 fax: 800-323-1640 investor.relations@apyxmedical.com http://www.apyxmedical.com

• General Corporate Information    Officers Charles D. Goodwin - Chief Executive Officer Stavros Vizirgianakis - Chairperson Shawn Roman - Chief Operating Officer Matthew Hill - Chief Financial Officer; Treasurer and Secretary Moshe Citronowicz - Senior Vice President Peer Information Apyx Medical Corporation (BJCT) Apyx Medical Corporation (CADMQ) Apyx Medical Corporation (APNO) Apyx Medical Corporation (UPDC) Apyx Medical Corporation (IMTIQ) Apyx Medical Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 03837C106 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/12/26 Share - Related Items Shares Outstanding: 38.24 Most Recent Split Date: 1.00 (0.07:1) Beta: 1.53 Market Capitalization: $133.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 21.77 Price/Cash Flow: - Price / Sales: 2.79 EPS Growth vs. Year Ago Period: 64.29% vs. Previous Quarter: 44.44% Sales Growth vs. Year Ago Period: 12.10% vs. Previous Quarter: 13.22% ROE 12/31/25 - - 09/30/25 - -151.01 06/30/25 - -158.22 ROA 12/31/25 - - 09/30/25 - -24.18 06/30/25 - -28.30 Current Ratio 12/31/25 - - 09/30/25 - 4.44 06/30/25 - 4.72 Quick Ratio 12/31/25 - - 09/30/25 - 3.61 06/30/25 - 3.95 Operating Margin 12/31/25 - - 09/30/25 - -30.35 06/30/25 - -37.11 Net Margin 12/31/25 - - 09/30/25 - -30.35 06/30/25 - -37.11 Pre-Tax Margin 12/31/25 - - 09/30/25 - -29.77 06/30/25 - -36.65 Book Value 12/31/25 - - 09/30/25 - 0.16 06/30/25 - 0.20 Inventory Turnover 12/31/25 - - 09/30/25 - 2.20 06/30/25 - 2.20 Debt-to-Equity 12/31/25 - - 09/30/25 - 5.69 06/30/25 - 4.61 Debt-to-Capital 12/31/25 - - 09/30/25 - 85.06 06/30/25 - 82.18

Powered by Zacks Investment Research ©